Article,
Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-a-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease
Affiliations
- [1] Lund Univ, Div Clin Neurophysiol, Inflammat & Stem Cell Therapy Grp, Dept Clin Sci, Lund, Sweden [NORA names: Sweden; Europe, EU; Nordic; OECD];
- [2] Svar Life Sci AB, Malmo, Sweden [NORA names: Sweden; Europe, EU; Nordic; OECD];
- [3] Karolinska Inst, Toxicol Unit, Inst Environm Med, Stockholm, Sweden [NORA names: Sweden; Europe, EU; Nordic; OECD];
- [4] Nord Biosci AS, Copenhagen, Denmark [NORA names: Nordic Bioscience; Private Research; Denmark; Europe, EU; Nordic; OECD];
- [5] Univ Penn, Ctr Neurodegenerat Dis Res, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA [NORA names: United States; America, North; OECD]
Abstract
Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.
Keywords
MHC class II genes,
MHC class II transactivator protein,
Parkinson's disease,
alpha-synuclein,
factor,
neuroinflammation,
tumor necrosis